Loading…
Fungal infections in immunocompromised critically ill patients
Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Ca...
Saved in:
Published in: | Journal of intensive medicine 2024-07, Vol.4 (3), p.299-306 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743 |
container_end_page | 306 |
container_issue | 3 |
container_start_page | 299 |
container_title | Journal of intensive medicine |
container_volume | 4 |
creator | Garnacho-Montero, José Barrero-García, Irene León-Moya, Cristina |
description | Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting. |
doi_str_mv | 10.1016/j.jointm.2024.01.005 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_53cf06ab63a7492aa26c304e06247c86</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2667100X2400015X</els_id><doaj_id>oai_doaj_org_article_53cf06ab63a7492aa26c304e06247c86</doaj_id><sourcerecordid>3083216754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743</originalsourceid><addsrcrecordid>eNp9UU1P3TAQtCpQQcA_qKoce3lh_ZnkglQhoEhIXDhws-yNgxw58audVOLf149Q1BMnr63ZGc8MId8o1BSouhzrMfp5mWoGTNRAawD5hZwypZodBXg--m8-IRc5jwDA2nKV3VdywjvgUlF2Sq5u1_nFhMrPg8PFxzmXsfLTtM4R47RPcfLZ9RUmv3g0IbxWPoRqbxbv5iWfk-PBhOwu3s8z8nR783T9a_fweHd__fNhh4LxZScoIreGIqe94J1VHIRtTK9Qcmd5OyiJnbUSsKeSg20pd0ZKY1nDeSP4GbnfaPtoRr1PfjLpVUfj9dtDTC_apPK_4LTkOIAyRcI0omPGMIVFzYFiosFWFa4fG1fx9nt1edHFIboQzOzimjWHljOqGnmQFRsUU8w5ueFDmoI-9KBHvfWgDz1ooLoEXNa-vyusdnL9x9K_1AvgagO4Etkf75LOWOJE1_tUWiim_OcKfwEcGZpE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3083216754</pqid></control><display><type>article</type><title>Fungal infections in immunocompromised critically ill patients</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Garnacho-Montero, José ; Barrero-García, Irene ; León-Moya, Cristina</creator><creatorcontrib>Garnacho-Montero, José ; Barrero-García, Irene ; León-Moya, Cristina</creatorcontrib><description>Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.</description><identifier>ISSN: 2667-100X</identifier><identifier>EISSN: 2667-100X</identifier><identifier>DOI: 10.1016/j.jointm.2024.01.005</identifier><identifier>PMID: 39035612</identifier><language>eng</language><publisher>China: Elsevier B.V</publisher><subject>Antifungal ; Critically ill patient ; Immunocompromised patient ; Invasive aspergillosis ; Invasive candidiasis ; Pneumocystis jirovecii</subject><ispartof>Journal of intensive medicine, 2024-07, Vol.4 (3), p.299-306</ispartof><rights>2024</rights><rights>2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743</cites><orcidid>0000-0003-2542-7601</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2667100X2400015X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3536,27905,27906,45761</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39035612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Barrero-García, Irene</creatorcontrib><creatorcontrib>León-Moya, Cristina</creatorcontrib><title>Fungal infections in immunocompromised critically ill patients</title><title>Journal of intensive medicine</title><addtitle>J Intensive Med</addtitle><description>Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.</description><subject>Antifungal</subject><subject>Critically ill patient</subject><subject>Immunocompromised patient</subject><subject>Invasive aspergillosis</subject><subject>Invasive candidiasis</subject><subject>Pneumocystis jirovecii</subject><issn>2667-100X</issn><issn>2667-100X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9UU1P3TAQtCpQQcA_qKoce3lh_ZnkglQhoEhIXDhws-yNgxw58audVOLf149Q1BMnr63ZGc8MId8o1BSouhzrMfp5mWoGTNRAawD5hZwypZodBXg--m8-IRc5jwDA2nKV3VdywjvgUlF2Sq5u1_nFhMrPg8PFxzmXsfLTtM4R47RPcfLZ9RUmv3g0IbxWPoRqbxbv5iWfk-PBhOwu3s8z8nR783T9a_fweHd__fNhh4LxZScoIreGIqe94J1VHIRtTK9Qcmd5OyiJnbUSsKeSg20pd0ZKY1nDeSP4GbnfaPtoRr1PfjLpVUfj9dtDTC_apPK_4LTkOIAyRcI0omPGMIVFzYFiosFWFa4fG1fx9nt1edHFIboQzOzimjWHljOqGnmQFRsUU8w5ueFDmoI-9KBHvfWgDz1ooLoEXNa-vyusdnL9x9K_1AvgagO4Etkf75LOWOJE1_tUWiim_OcKfwEcGZpE</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Garnacho-Montero, José</creator><creator>Barrero-García, Irene</creator><creator>León-Moya, Cristina</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2542-7601</orcidid></search><sort><creationdate>20240701</creationdate><title>Fungal infections in immunocompromised critically ill patients</title><author>Garnacho-Montero, José ; Barrero-García, Irene ; León-Moya, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antifungal</topic><topic>Critically ill patient</topic><topic>Immunocompromised patient</topic><topic>Invasive aspergillosis</topic><topic>Invasive candidiasis</topic><topic>Pneumocystis jirovecii</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Barrero-García, Irene</creatorcontrib><creatorcontrib>León-Moya, Cristina</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of intensive medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garnacho-Montero, José</au><au>Barrero-García, Irene</au><au>León-Moya, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fungal infections in immunocompromised critically ill patients</atitle><jtitle>Journal of intensive medicine</jtitle><addtitle>J Intensive Med</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>4</volume><issue>3</issue><spage>299</spage><epage>306</epage><pages>299-306</pages><issn>2667-100X</issn><eissn>2667-100X</eissn><abstract>Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.</abstract><cop>China</cop><pub>Elsevier B.V</pub><pmid>39035612</pmid><doi>10.1016/j.jointm.2024.01.005</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-2542-7601</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2667-100X |
ispartof | Journal of intensive medicine, 2024-07, Vol.4 (3), p.299-306 |
issn | 2667-100X 2667-100X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_53cf06ab63a7492aa26c304e06247c86 |
source | ScienceDirect Journals; PubMed Central |
subjects | Antifungal Critically ill patient Immunocompromised patient Invasive aspergillosis Invasive candidiasis Pneumocystis jirovecii |
title | Fungal infections in immunocompromised critically ill patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A50%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fungal%20infections%20in%20immunocompromised%20critically%20ill%20patients&rft.jtitle=Journal%20of%20intensive%20medicine&rft.au=Garnacho-Montero,%20Jos%C3%A9&rft.date=2024-07-01&rft.volume=4&rft.issue=3&rft.spage=299&rft.epage=306&rft.pages=299-306&rft.issn=2667-100X&rft.eissn=2667-100X&rft_id=info:doi/10.1016/j.jointm.2024.01.005&rft_dat=%3Cproquest_doaj_%3E3083216754%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423t-41cc3ba1c31d439b6304b7ad6c53eb38f65c9bb50cd1530b813ea55ab2733743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3083216754&rft_id=info:pmid/39035612&rfr_iscdi=true |